FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Dyspepsia
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• Ranitidine (Ranitidine)

Snippet

SUPPL AP for RANITIDINE (RANITIDINE)